NORTH CAROLINA - North Carolina has won $38.8 million as part of a Medicaid fraud settlement from Johnson & Johnson.
The settlement resolves allegations that Johnson & Johnson improperly marketed some drugs, Attorney General Roy Cooper announced Wednesday.
Johnston & Johnston and it's subsidiary, Janssen Pharmaceuticals, improperly marketed the atypical anti-psychotic drugs Risperdal and Invega, according to the N.C. Department of Justice. North Carolina and other states alleged that those drugs were marketed for uses not approved by the Food and Drug Administration.
The $38.8 million that North Carolina will be receiving is part a $1.2 billion settlement with several states and the federal government.
- Updated Autism link to herpes during pregnancy may be overstated, experts say
- New Silver Alert issued for missing Beaufort County man
- New North Carolina lawmaker introduces 'life at conception' bill
- Updated Verizon to test 5G in 11 cities
- Updated Astronomers discover 7 Earth-sized planets orbiting nearby star